Booster dose of Pfizer and BioNTech's coronavirus vaccine has received FDA approval for emergency use in persons 65 years of age and older. The drug can also be used for persons 18 to 64 years of age with a high risk of severe COVID-19 or with a high risk of acquiring the virus because of occupational exposure.
Booster dose of Pfizer and BioNTech's coronavirus vaccine has received FDA approval for emergency use in persons 65 years of age and older. The drug can also be used for persons 18 to 64 years of age with a high risk of severe COVID-19 or with a high risk of acquiring the virus because of occupational exposure. 
investors.pfizer.com
English (US) 